Drug intelligence / Profile preview

Eutha 77

Development stage
Unknown
Lead developer
Virbac
Modality
Small Molecules
Administration
Intravenous
01

Overview

Eutha 77 is a veterinary euthanasia solution manufactured by Virbac AH, Inc., specifically indicated for the humane and rapid euthanasia of dogs. It is a combination of two active ingredients: pentobarbital sodium (390 mg/mL) and phenytoin sodium (50 mg/mL). Pentobarbital sodium is a barbiturate that acts as a potent central nervous system depressant, targeting the medullary respiratory and vasomotor centers to induce deep anesthesia followed by respiratory arrest. Phenytoin sodium provides complementary cardiotoxic effects, accelerating the cessation of the heart's electrical activity. The formulation is a non-sterile intravenous solution containing rhodamine B dye as a visual safety indicator and benzyl alcohol as a bacteriostat. Its use is restricted to licensed veterinarians and is strictly prohibited in animals intended for human consumption.

Brand names
Eutha 77Eutha77Eutha-77
02

Targets

GABRR (GABA-A receptor subunit rho)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on Eutha 77.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eutha 77.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call